BioTech IQ
BioTech IQ
Sep 25, 2020
#4 Ross O. Youngs - Founder and CEO of Biosortia Pharmaceuticals
Play • 46 min

Through an interesting turn of events Biosortia discovered they had access to large amounts of Aquatic Microbiome. With a broad range of capabilities they are able to extrapolate this into drug discovery. Ross believes that Biosortias ability to mine microbiome on such a large scale will change drug discovery in the coming years. 

More episodes
Clear search
Close search
Google apps
Main menu